EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peripheral Serotonergic Activation in Severe Aortic Stenosis: A Biochemical Perspective

Denisa Bianca Mercean iD, Raluca Tomoaia iD, Ioana Berindan-Neagoe iD, Liviuţa Budişan iD, Dana Pop iD, Adela Mihaela Șerban, Carmen Stanca Melincovici, Carmen Mihaela Mihu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Denisa Bianca Mercean und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Morpho-functional Sciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Serotonin, Aortic Valve Stenosis, Hydroxyindoleacetic Acid. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The involvement of the serotoninergic system in the pathogenesis of calcific aortic stenosis introduced a novel dimension to our understanding of this complex cardiovascular condition. This study aimed to assess serotonin (5-HT) and its main metabolite, 5-Hydroxyindoleacetic acid (5-HIAA) in patients with severe aortic valve stenosis (AS). The study employed a case–control design, including 76 patients who underwent transthoracic echocardiography, computed tomography (CT), and peripheral blood sampling. Serum concentrations of 5-HT and 5-HIAA were quantified using enzyme-linked immunosorbent assay (ELISA). The severe aortic valve stenosis group exhibited significantly elevated levels of 5-HT and 5-HIAA compared to the control group (5-HT 1066.5 ng/mL (IQR = 961.9–1112 ng/mL) vs. 977.4 ng/mL (IQR = 394.3–1097.9 ng/mL); p = 0.034 and 5-HIAA 57 ± 12.7 ng/mL vs. 47.5 ± 15.3 ng/mL; p = 0.004, respectively). Receiver operating characteristic (ROC) analysis revealed that 5-HT predicted severe AS with a sensitivity of 73.7% and specificity of 50% at a cut-off level > 973.5 ng/mL, whereas 5-HIAA exhibited a sensitivity of 86.8% and specificity of 47.4% when a cut-off level > 45.49 ng/mL was used. This study showed a significant elevation in the 5-HT and 5-HIAA among patients with severe AS, further supporting the potential involvement of the peripheral serotonergic system in the pathophysiology of this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerotoninAortic Valve StenosisHydroxyindoleacetic AcidHumansMaleFemaleAgedCase-Control StudiesROC CurveMiddle AgedBiomarkersSeverity of Illness IndexAortic ValveEchocardiographyAged, 80 and over

Stichwörter der Autor:innen

5-HIAA5-HTELISAaortic stenosisserotonin

Substanzen

SerotoninHydroxyindoleacetic AcidBiomarkers

Autor:innen und Institutionen

  • 1st Department of Morpho-functional Sciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Cardiology Department, Heart Institute "N. Stăncioiu", 400001 Cluj-Napoca, Romania.
  • 4th Department of Internal Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Cardiology Department, Rehabilitation Hospital, 400347 Cluj-Napoca, Romania.
  • Genomics Department, MEDFUTURE Institute of Biomedical Research, "Iuliu Hatieganu" University of Medicine and Pharmacy, 23 Marinescu Street, 400337 Cluj-Napoca, Romania.
  • Doctoral School, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babeş Street, 400012 Cluj-Napoca, Romania.

ORCID-Profile: Denisa Bianca Mercean, Raluca Tomoaia, Ioana Berindan-Neagoe, Liviuţa Budişan, Dana Pop

Förderung

  • "Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca
  • “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca

Zitieren

APA

Mercean, D. B., Tomoaia, R., Berindan-Neagoe, I., Budişan, L., Pop, D., Șerban, A. M., Melincovici, C. S., & Mihu, C. M. (2025). Peripheral Serotonergic Activation in Severe Aortic Stenosis: A Biochemical Perspective. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110250

Vancouver

Mercean DB, Tomoaia R, Berindan-Neagoe I, Budişan L, Pop D, Șerban AM, et al. Peripheral Serotonergic Activation in Severe Aortic Stenosis: A Biochemical Perspective. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110250

BibTeX
@article{Mercean2025,
  author = {Mercean, Denisa Bianca and Tomoaia, Raluca and Berindan-Neagoe, Ioana and Budişan, Liviuţa and Pop, Dana and Șerban, Adela Mihaela and Melincovici, Carmen Stanca and Mihu, Carmen Mihaela},
  title = {Peripheral Serotonergic Activation in Severe Aortic Stenosis: A Biochemical Perspective},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110250}
}
Kostenlos starten →